Table 4.
Study details | GA (weeks) | BW (gr) | Risk factors |
---|---|---|---|
Reyes et al., 2017. Oman [46] | < 32 | < 1500 | low BW, low GA, duration of invasive ventilation, duration of oxygen therapy, duration of nasal CPAP, late onset clinical or proven sepsis |
Shah et al., 2005 Singapore [40] | < 32 | < 1500 | Preeclampsia, low BW, prolonged duration of ventilation, pulmonary hemorrhage and CPAP |
Yau et al., 2016, China [45] | < 32 and > 32 | < 1500 | low GA, low BW, preeclampsia, gestational diabetes mellitus, inotrope use, postnatal hypotension, apgar score (1 min, 5 min and 10 min), respiratory distress syndrome, bronchopulmonary dysplasia, invasive mechanical ventilation, surfactant use, oxygen supplement, patent ductus arteriosus, thrombocytopenia, blood transfusion, anemia, NSAID use, sepsis |
Abdel HA et al., 2012, Egypt [34] | < 32 and > 32 | < 1500 and > 1500 | low GA, oxygen therapy, frequency of blood transfusions and sepsis |
Chen et al., 2011, USA [41] | < 30 | < 1500 | low GA, Sepsis, oxygen exposure |
Hadi and Hamdy, 2013, Egypt [37] | < 32 | < 1250 | low GA, low BW, Ventilation, blood transfusions, sepsis, Patent ductus arteriosus, IVH |
Nair et al., 2001, Oman [36] | < 32 | < 1500 | low BW, Low GA, TPN |
BW Birth weight, GA Gestational age, PDA Patent ductus arteriosus, CPAP Continuous positive pressure ventilation, IVH Intraventricular hemorrhage, TPN Total parenteral nutrition